12 HR chlorpheniramine maleate 8 MG / codeine phosphate 54.3 MG Extended Release Oral Tablet [Tuxarin]
RxNorm concept 2099286, branded drug (sbd). Prescribable name: Tuxarin ER 54.3 MG / 8 MG 12HR Extended Release Oral Tablet.
- RxCUI
- 2099286
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2099286 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Tuxarin 54.3 MG / 8 MG 12 HR Extended Release Oral Tablet
Related concepts
- chlorpheniramine maleate 8 MG (SCDC, consists of)
- codeine phosphate 54.3 MG (SCDC, consists of)
- chlorpheniramine maleate 8 MG / codeine phosphate 54.3 MG [Tuxarin] (SBDC, consists of)
- Extended Release Oral Tablet (DF, has dose form)
- Tuxarin (BN, has ingredient)
- 12 HR chlorpheniramine maleate 8 MG / codeine phosphate 54.3 MG Extended Release Oral Tablet (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2099286 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2099286 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2099286. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.